Intercept Pharma Drops On Downgrade, Despite FDA Panel’s Yes Vote

Shares of Intercept Pharmaceuticals (ICPT) were falling Friday after Morgan Stanley downgraded the stock, saying that a positive FDA panel vote nonetheless pointed toward a restrictive label for its lead drug.

Trading in Intercept stock was halted all day Thursday as the advisory committee discussed obeticholic acid, now branded Ocaliva, eventually resulting in a 17-to-0 vote in favor of approving the drug to treat a rare liver disease called primary biliary cholangitis (PBC). The FDA will...

What feeling does this article give you?

#hashtags to follow:

Shares of Intercept Pharmaceuticals [+]    ICPT [+]    Morgan Stanley [+]    FDA [+]    Intercept [+]    Ocaliva [+]    PBC [+]   

More #news: